Novel Detector for Disease Diagnosis and Assessment
By LabMedica International staff writers Posted on 10 Feb 2015 |
A research consortium developing a compact, noninvasive detector for life-threatening disease has received a EUR 6 million grant from the European Commission (EC; Brussels, Belgium). The grant will enable the consortium build a link between the detector and smartphones as part of the SNIFFPHONE project.
The product is intended for use in early-stage, rapid, and inexpensive detection of serious disease in high-risk groups in the general population. The product uses an 'electronic nose' consisting of micro- and nano-sensors to analyze a person's exhaled breath. The data is transferred by the smartphone to an information processing system for disease diagnosis.
The technology was developed at the Technion-Israel Institute of Technology (Haifa, Israel) by Prof. Hossam Haick, Dr. Gregory Shuster, and Sagi Gliksman.
The research consortium includes NanoVation-GS Israel (Ramat Yishai, Israel), universities and research institutes from Latvia, Ireland, Finland, and Germany, and the company Siemens (Munich, Germany).
Professor Haick commented, “The SNIFFPHONE is a winning solution. It will be made tinier and cheaper than disease detection solutions currently, consume little power, and most importantly, it will enable immediate and early diagnosis that is both accurate and non-invasive. Early diagnosis can save lives, particularly in life-threatening diseases such as cancer.”
Related Links:
Technion-Israel Institute of Technology
NanoVation-GS Israel
Siemens
The product is intended for use in early-stage, rapid, and inexpensive detection of serious disease in high-risk groups in the general population. The product uses an 'electronic nose' consisting of micro- and nano-sensors to analyze a person's exhaled breath. The data is transferred by the smartphone to an information processing system for disease diagnosis.
The technology was developed at the Technion-Israel Institute of Technology (Haifa, Israel) by Prof. Hossam Haick, Dr. Gregory Shuster, and Sagi Gliksman.
The research consortium includes NanoVation-GS Israel (Ramat Yishai, Israel), universities and research institutes from Latvia, Ireland, Finland, and Germany, and the company Siemens (Munich, Germany).
Professor Haick commented, “The SNIFFPHONE is a winning solution. It will be made tinier and cheaper than disease detection solutions currently, consume little power, and most importantly, it will enable immediate and early diagnosis that is both accurate and non-invasive. Early diagnosis can save lives, particularly in life-threatening diseases such as cancer.”
Related Links:
Technion-Israel Institute of Technology
NanoVation-GS Israel
Siemens
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability